相关实验视频

Updated: Jul 12, 2025

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

免疫检查点抑制剂在血液恶性瘤中的有效性和安全性

Muhammed Talha Bilgihan¹, Ayse Nur Eryigit¹, Rafiye Ciftciler²

¹Selcuk University Faculty of Medicine, Konya, Turkey.

Clinical lymphoma, myeloma & leukemia

|October 20, 2023

概括

免疫检查点抑制剂 (ICI) 在血液癌症中表现出不同的疗效,组合疗法改善了结果. 由于潜在的副作用,仔细监测至关重要,指导个性化治疗策略.

科学领域:

血液学血液学血液学
在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

免疫检查点抑制剂 (ICI) 已经彻底改变了癌症治疗.
它们在血液性恶性瘤中的应用是激烈研究兴趣的领域.

研究的目的:

综合审查ICI在血液恶性瘤中的疗效和安全性.
评估ICI作为单疗法和组合疗法.

主要方法:

对血液癌症中ICI现有研究的系统文献综述.
对不同血液性恶性瘤亚型的治疗反应,安全性概况和结果的分析.

主要成果:

在血液恶性瘤中,ICI的疗效不同;霍奇金淋巴瘤和一些非霍奇金淋巴瘤显示出有希望的反应.
与单一治疗相比,组合疗法通常会产生更好的结果.
与免疫相关的不良事件需要仔细监测和管理.

结论:

在治疗血液癌症方面,ICI具有潜在的益处,但有效性取决于亚型.
结合生物标志物的定制治疗方法是必不可少的.
对最佳组合策略的进一步研究是有必要的,以改善患者的治疗结果.

关键词:

血液的恶性瘤.免疫检查点抑制剂免疫检查点抑制剂在白血病中,白血病.淋巴瘤是一种淋巴瘤.多发性骨髓瘤是一种多发性骨髓瘤.

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.